Publications
Nightingale Health’s technology is routinely used in world-class epidemiological and genetic studies. There are over 450 publications that have utilized our technology.
All
Ageing
Bioinformatics
Cancer
Cardiovascular diseases
Drug development
Fatty liver disease
Gut microbiota
Human genetics
Kidney disease
Maternal health
Metabolic risk factors
Method description
Neurological diseases
Nutrition
T1D
T2D
Inflammation
Sarin et al. FASEB J. 2021 Apr;35(4):e21484
Cardiovascular diseases
Increased apolipoprotein-B:A1 ratio predicts cardiometabolic risk in patients with juvenile onset SLE
Robinson et al. EBioMedicine. 2021 Mar;65:103243
Cardiovascular diseases
Association of circulating metabolites in plasma or serum and risk of stroke: Meta-analysis from seven prospective cohorts
Vojinovic et al. Neurology. 2020 Dec 2;96(8):e1110–23
Schmidt et al. Metabolites. 2021; 11(2):121
Schmidt et al. Metabolites. 2021; 11(2):121
Metabolic risk factors
Population epidemiology and concordance for plasma amino acids and precursors in 11-12-year-old children and their parents
Andraos et al. Scientific Reports. 2021 Feb 11;11(1):3619
Metabolic risk factors
Improved lipidomic profile mediates the effects of adherence to healthy lifestyles on coronary heart disease
Si et al. Elife. 2021 Feb 9;10:e60999.
Lehtovirta et al. Nutrients 2021; Feb 6;13(2):533
Cardiovascular diseases
Serum Metabolomic Signatures Can Predict Subclinical Atherosclerosis in Patients With Systemic Lupus Erythematosus
Coelewij et al. Arteriosclerosis, Thrombosis, and Vascular Biology. 2021;41:1446–1458
Cardiovascular diseases
The associations of oxidized lipoprotein lipids with lipoprotein subclass particle concentrations and their lipid compositions. The Cardiovascular Risk in Young Finns Study.
Kresanov et al. Free Radic Biol Med. 2021 Jan;162:225-232
Gut microbiota
Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals
Asnicar et al. Nat Med. 2021 Feb;27(2):321-332
Human genetics
A cross-platform approach identifies genetic regulators of human metabolism and health
Lotta et al. Nat Genet 53, 54–64 (2021)
Gomez-Alonso et al. Clin Epigenetics. 2021 Jan 7;13(1):7
Drug development
Metabolic profiling of angiopoietin-like protein 3 and 4 inhibition: a drug-target Mendelian randomization analysis
Wang et al. European Heart Journal, Volume 42, Issue 12, 21 March 2021, Pages 1160–1169
Metabolic risk factors
Adiposity, metabolites, and colorectal cancer risk: Mendelian randomization study.
Bull et al. BMC Med 18, 396 (2020).